Protagonist Therapeutics Inc Cash Flow Quality Index

Latest as of December 2024: -0.22x

Protagonist Therapeutics Inc cash flow quality index. Protagonist Therapeutics Inc (PTGX) has a Cash Flow Quality Index of -0.22x as of December 2024. Operating cash flow of $-29.18 Million is below net income of $131.67 Million, suggesting accrual-heavy earnings not yet converted to cash. See Protagonist Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.22x

Operating CF / Net Income

Operating Cash Flow

$-29.18 Million

USD

Net Income

$131.67 Million

USD

Data as of

Dec 2024

Most recent filing

Cash Flow Quality Index of Protagonist Therapeutics Inc (2024–2024)

Cash flow quality index of Protagonist Therapeutics Inc from 2024 to 2024. Historical Cash Flow Quality Index for Protagonist Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Protagonist Therapeutics Inc (PTGX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Protagonist Therapeutics Inc Cash Flow Quality Index by Year (2024–2024)

Protagonist Therapeutics Inc cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Protagonist Therapeutics Inc. For the full cash flow conversion analysis, see Protagonist Therapeutics Inc cash flow conversion.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2024	0.67x	$184.15 Million	$275.19 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.